Read More Restaurant Industry News Chinese regulator accepts NDA of BeiGene’s pamiparib in ovarian cancer BeiGene said that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has… bypharmanewsdailyJuly 19, 2020